Lingpu Zhang

1.1k total citations · 1 hit paper
24 papers, 756 citations indexed

About

Lingpu Zhang is a scholar working on Biomedical Engineering, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lingpu Zhang has authored 24 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lingpu Zhang's work include Nanoplatforms for cancer theranostics (10 papers), RNA Interference and Gene Delivery (4 papers) and Photodynamic Therapy Research Studies (4 papers). Lingpu Zhang is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), RNA Interference and Gene Delivery (4 papers) and Photodynamic Therapy Research Studies (4 papers). Lingpu Zhang collaborates with scholars based in China, United States and Germany. Lingpu Zhang's co-authors include Haihua Xiao, Dongsheng Tang, Mingshuai Wang, Feiya Yang, Lu Yin, Sujun Han, Nianzeng Xing, Wenkuan Wang, Boda Guo and Dong Chen and has published in prestigious journals such as Advanced Materials, Nature Communications and Biomaterials.

In The Last Decade

Lingpu Zhang

20 papers receiving 750 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy

2023 286 citations Boda Guo, Feiya Yang et al. Advanced Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingpu Zhang China	13	373	273	177	161	148	24	756
Lingpu Zhang China	11	339 0.9×	237 0.9×	171 1.0×	100 0.6×	176 1.2×	15	615
Chaoming Mei China	16	360 1.0×	270 1.0×	222 1.3×	63 0.4×	149 1.0×	25	744
Qianyuan He China	14	445 1.2×	263 1.0×	160 0.9×	149 0.9×	159 1.1×	21	814
Jia Tan China	15	518 1.4×	342 1.3×	292 1.6×	194 1.2×	125 0.8×	33	902
Qi Meng China	10	391 1.0×	231 0.8×	177 1.0×	118 0.7×	101 0.7×	18	606
Jianhao Lai China	11	609 1.6×	261 1.0×	240 1.4×	251 1.6×	170 1.1×	18	1.0k
Pilar Acedo United Kingdom	15	391 1.0×	239 0.9×	197 1.1×	68 0.4×	195 1.3×	32	788
Yu‐Yi Ling China	15	376 1.0×	662 2.4×	181 1.0×	138 0.9×	55 0.4×	21	1.1k
Zilin Guan China	10	338 0.9×	130 0.5×	144 0.8×	84 0.5×	137 0.9×	13	526

Countries citing papers authored by Lingpu Zhang

Since Specialization

Citations

This map shows the geographic impact of Lingpu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingpu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingpu Zhang more than expected).

Fields of papers citing papers by Lingpu Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingpu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingpu Zhang. The network helps show where Lingpu Zhang may publish in the future.

Co-authorship network of co-authors of Lingpu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingpu Zhang. A scholar is included among the top collaborators of Lingpu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingpu Zhang. Lingpu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, He, Yi Sun, Lingpu Zhang, et al.. (2025). Polymer‐PARPi Conjugates Delivering USP1i for Maximizing Synthetic Lethality to Stimulate STING Pathway in High‐Grade Serous Ovarian Cancer. Advanced Materials. 38(2). e12962–e12962. 1 indexed citations

Jiang, Yuhong, Yuke Li, Dongmei Zheng, et al.. (2025). Nano-polymeric platinum activates PAR2 gene editing to suppress tumor metastasis. Biomaterials. 317. 123090–123090. 3 indexed citations

Zhang, Lingpu, et al.. (2025). Unconditionally Stable Leapfrog Complying-Divergence Implicit FDTD Method With Lumped Elements. IEEE Transactions on Antennas and Propagation. 73(11). 9271–9284.

Tang, Dongsheng, Lingpu Zhang, Hanchen Zhang, et al.. (2025). A Novel Zinc(II) Complex for Sonodynamic Therapy Induces Pyroptosis of Breast Cancer Cells and Enhances Anti‐Tumor Immune Response. Advanced Science. 12(47). e08155–e08155.

Wang, Ke, Li Li, Ganghao Liang, et al.. (2025). Sonodynamic activated nanoparticles with Glut1 inhibitor and cystine-containing polymer stimulate disulfidptosis for improved immunotherapy in bladder cancer. Biomaterials. 319. 123178–123178. 13 indexed citations

Zhang, He, Lingpu Zhang, Haihua Xiao, et al.. (2025). GSH-responsive nanoparticles enhance ovarian cancer chemo-immunotherapy via DNA damage repair pathway inhibition and cGAS-STING pathway activation. Nano Today. 62. 102729–102729. 3 indexed citations

Shang, Kun, Nicolás Montesdeoca, Hanchen Zhang, et al.. (2024). Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy. Journal of Controlled Release. 373. 493–506. 10 indexed citations

Zhang, Lingpu, et al.. (2024). One‐Step Leapfrog 3D Split‐Field FDTD Method for Periodic Structures at Oblique Incidence. International Journal of Numerical Modelling Electronic Networks Devices and Fields. 37(6).

Zhu, Yihao, Yajian Li, Xu‐Wen Li, et al.. (2024). Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF‐2α Inhibitor for Enhancing Immunotherapy in Renal Cell Carcinoma. Advanced Healthcare Materials. 13(32). e2402973–e2402973. 4 indexed citations

10.

Zhou, Huiling, Dongsheng Tang, Yingjie Yu, et al.. (2023). Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway. Nature Communications. 14(1). 5350–5350. 81 indexed citations

11.

Zhang, Jinbo, et al.. (2023). Light-activated PEG deshielding core–shell nanoparticles for enhanced chemo-photodynamic combination therapy. Nanoscale. 15(22). 9783–9791. 6 indexed citations

12.

Zhang, Lingpu, Lin Tang, Changyuan Yu, Haihua Xiao, & Chaoyong Liu. (2023). Targeting Hypoxic Tumor Plasticity for Recapturing Photodynamic‐Immunotherapy Sensitivity via Fluorinated Polysensitizers. Advanced Functional Materials. 34(8). 12 indexed citations

13.

Shang, Kun, Lingpu Zhang, Yingjie Yu, et al.. (2023). Disulfide-containing polymer delivery of C527 and a Platinum(IV) prodrug selectively inhibited protein ubiquitination and tumor growth on cisplatin resistant and patient-derived liver cancer models. Materials Today Bio. 18. 100548–100548. 15 indexed citations

14.

Zhang, Li, Lingpu Zhang, Kai Jiang, et al.. (2023). Regulating the surface topography of CpG nanoadjuvants via coordination-driven self-assembly for enhanced tumor immunotherapy. Nanoscale Advances. 5(18). 4758–4769. 7 indexed citations

15.

Tang, Dongsheng, et al.. (2023). NIR light triggered intracellular polymerization via nanoparticles containing acrylates prodrugs and azo-polymers for inhibiting cisplatin efflux for combined chemotherapy and immunotherapy. Nano Today. 50. 101858–101858. 22 indexed citations

16.

Guo, Boda, Feiya Yang, Lingpu Zhang, et al.. (2023). Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy. Advanced Materials. 35(22). e2212267–e2212267. 286 indexed citations breakdown →

17.

Zhang, Lingpu, Lin Tang, Jiayi Xie, et al.. (2022). Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy. Advanced Science. 10(3). e2205246–e2205246. 47 indexed citations

18.

Li, Xing, Lingpu Zhang, Tuo Li, et al.. (2022). Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin. Journal of Nanobiotechnology. 20(1). 258–258. 17 indexed citations

19.

Weng, Rui, Linghao Zhang, Xinlu Wang, et al.. (2022). Simulation guided intramolecular orthogonal reporters for dissecting cellular oxidative stress and response. Nano Today. 46. 101573–101573. 19 indexed citations

20.

Ding, Fang, Lingpu Zhang, Hao Chen, et al.. (2020). Enhancing the chemotherapeutic efficacy of platinum prodrug nanoparticles and inhibiting cancer metastasis by targeting iron homeostasis. Nanoscale Horizons. 5(6). 999–1015. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact